Raeven, Pierre
Baron-Stefaniak, Joanna
Simbrunner, Benedikt
Stadlmann, Alexander
Schwabl, Philipp
Scheiner, Bernhard
Schaden, Eva
Eigenbauer, Ernst
Quehenberger, Peter
Mandorfer, Mattias
Baron, David Marek
Reiberger, Thomas http://orcid.org/0000-0002-4590-3583
Funding for this research was provided by:
Medical-Scientific Fund of the Mayor of Vienna
Gilead International Research Scholar Award
Medical University of Vienna
Article History
Received: 20 June 2020
Accepted: 6 September 2020
First Online: 30 September 2020
Compliance with ethical standards
:
: B.S. received travel support from AbbVie and Gilead. P.S. received speaking honoraria from Bristol-Myers Squibb and Boehringer-Ingelheim, consulting fees from PharmaIN, and travel support from Falk. M.M. served as a speaker and/or consultant and/or advisory board member for AbbVie, Bristol-Myers Squibb, Gilead, and W. L. Gore & Associates and received travel support from AbbVie, Bristol-Myers Squibb, and Gilead. T.R. received grant support from AbbVie, Boehringer-Ingelheim, Gilead, MSD, Philips Healthcare, Gore; speaking honoraria from AbbVie, Gilead, Gore, Intercept, Roche, MSD; consulting/advisory board fee from AbbVie, Bayer, Boehringer-Ingelheim, Gilead, Intercept, MSD, Siemens; and travel support from Boehringer-Ingelheim, Gilead and Roche. None of the remaining authors declares a conflict of interest for this manuscript.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional review board of the Medical University of Vienna (1262/2017) and with the 1964 Helsinki declaration and its later amendments.